Georgia D Tomaras Selected Research

AIDS Vaccines

1/2021	Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
10/2018	Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV.
1/2018	HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
1/2018	IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells.
1/2018	Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques.
1/2018	HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition.
11/2017	DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.
10/2017	Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
1/2017	HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
1/2017	Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georgia D Tomaras Research Topics

Disease

107	Infections 01/2022 - 01/2007
13	HIV Infections (HIV Infection) 01/2020 - 02/2007
12	Vaccinia 01/2020 - 03/2011
10	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 12/2005
8	Viremia 01/2022 - 01/2005
6	Persistent Infection 01/2020 - 01/2010
5	Communicable Diseases (Infectious Diseases) 04/2021 - 10/2007
5	Virus Diseases (Viral Diseases) 01/2020 - 11/2013
5	Human Influenza (Influenza) 01/2014 - 07/2009
4	Malaria 08/2021 - 01/2018
3	Typhoid Fever (Typhoid) 10/2021 - 01/2019
2	Disease Progression 01/2020 - 08/2014
2	Hypersensitivity (Allergy) 11/2019 - 10/2007
2	Vesicular Stomatitis 11/2017 - 09/2015
1	COVID-19 10/2021
1	Pain (Aches) 10/2021
1	Headache (Headaches) 10/2021
1	Parasitemia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Back Pain (Backache) 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Eye Infections 10/2017
1	Eye Diseases (Eye Disease) 10/2017
1	Neonatal herpes 10/2017
1	Blindness (Hysterical Blindness) 10/2017
1	Herpes Labialis (Fever Blister) 10/2017

Drug/Important Bio-Agent (IBA)

73	VaccinesIBA 10/2021 - 02/2007
49	AntibodiesIBA 10/2021 - 01/2008
26	Immunoglobulin G (IgG)IBA 01/2021 - 12/2008
23	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2009
18	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2011
17	AIDS VaccinesIBA 01/2021 - 02/2007
16	Immunoglobulin A (IgA)IBA 11/2019 - 04/2012
14	AntigensIBA 01/2020 - 10/2011
12	Neutralizing AntibodiesIBA 01/2022 - 01/2010
11	Broadly Neutralizing AntibodiesIBA 01/2022 - 09/2010
11	EpitopesIBA 01/2021 - 01/2008
8	Monoclonal AntibodiesIBA 01/2022 - 04/2010
8	Glycoproteins (Glycoprotein)IBA 01/2018 - 05/2008
6	GP 140IBA 01/2020 - 11/2011
6	Antiviral Agents (Antivirals)IBA 10/2017 - 11/2011
5	env Gene ProductsIBA 11/2019 - 08/2011
4	A-Form DNA (A-DNA)IBA 11/2019 - 11/2013
3	Polysaccharides (Glycans)IBA 01/2022 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 01/2017
3	MF59 oil emulsionIBA 01/2018 - 02/2015
3	Hemagglutinins (Hemagglutinin)IBA 01/2014 - 01/2011
3	RNA (Ribonucleic Acid)IBA 11/2013 - 01/2005
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 08/2021 - 01/2021
2	Lipid NanoparticlesIBA 04/2021 - 12/2020
2	Messenger RNA (mRNA)IBA 04/2021 - 12/2020
2	NucleosidesIBA 04/2021 - 12/2020
2	Fc Receptors (Fc Receptor)IBA 01/2021 - 09/2014
2	aluminum sulfate (alum)IBA 01/2021 - 02/2015
2	Recombinant ProteinsIBA 04/2020 - 01/2007
2	Pharmaceutical PreparationsIBA 11/2018 - 04/2014
2	Immunoglobulin M (IgM)IBA 12/2017 - 12/2008
2	DNA VaccinesIBA 11/2017 - 01/2016
2	Amino Acids FDA Link 01/2014 - 09/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 01/2014
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2011 - 08/2009
1	Carrier Proteins (Binding Protein)IBA 10/2021
1	Malaria VaccinesIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Combined VaccinesIBA 10/2020
1	ImmunosorbentsIBA 01/2020
1	EnzymesIBA 01/2020
1	MucinsIBA 01/2020
1	retanefIBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 11/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 11/2018
1	AerosolsIBA 10/2018
1	AluminumIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Vaccine AdjuvantsIBA 01/2018
1	AIDSVAXIBA 01/2018
1	InflammasomesIBA 01/2018
1	MVA vaccineIBA 12/2017
1	Interleukin-12 (IL 12)IBA 11/2017
1	Virus ReceptorsIBA 10/2017
1	NectinsIBA 10/2017
1	Immunoglobulin IsotypesIBA 04/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2017
1	nanolucIBA 12/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2011
2	Art Therapy 11/2018 - 01/2017
1	Intravenous Injections 10/2021
1	Microspheres (Microsphere) 01/2021
1	Injections 01/2019
1	Intramuscular Injections 01/2018